A-458 - InterPATH-001 trial in progress: Adjuvant V940 (mRNA-4157) with pembrolizumab versus placebo in patients with high-risk stage II-IV melanoma
Autor: | Weber, J.S., Luke, J.J., Carlino, M.S., Khattak, M.A., Meehan, R., Brown, M., Zhang, J., Krepler, C., Duic, J.P., Long, G.V. |
---|---|
Zdroj: | In EJC Skin Cancer 2024 2 Supplement 1 |
Databáze: | ScienceDirect |
Externí odkaz: |